145 related articles for article (PubMed ID: 12823589)
41. Molecular cytogentic profiles of hepatitis C infection in patients at Sharkia Governorate, Egypt.
el-Sobky E; Mangoud AM; Mahrous S; Eissa MH; Sabee EI; Ibrahem IA; Ismail A; Morsy TA; Nor Edin E; el-Naggar I; Mostafa Y; Abuel-Magd Y; Afefy AF; el-Shorbagy E; el-Sadawy M; Ragab H; el-Far A; Hassan MI; Lakouz K; Abdel-Aziz K; Saber M; el-Hady G
J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):401-15. PubMed ID: 15124749
[TBL] [Abstract][Full Text] [Related]
42. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis C virus infection triggers a tumor-like glutamine metabolism.
Lévy PL; Duponchel S; Eischeid H; Molle J; Michelet M; Diserens G; Vermathen M; Vermathen P; Dufour JF; Dienes HP; Steffen HM; Odenthal M; Zoulim F; Bartosch B
Hepatology; 2017 Mar; 65(3):789-803. PubMed ID: 27863447
[TBL] [Abstract][Full Text] [Related]
45. Multiple binding of repressed mRNAs by the P-body protein Rck/p54.
Ernoult-Lange M; Baconnais S; Harper M; Minshall N; Souquere S; Boudier T; Bénard M; Andrey P; Pierron G; Kress M; Standart N; le Cam E; Weil D
RNA; 2012 Sep; 18(9):1702-15. PubMed ID: 22836354
[TBL] [Abstract][Full Text] [Related]
46. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
47. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
48. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma.
Sansonno D; Cornacchiulo V; Racanelli V; Dammacco F
Cancer; 1997 Jul; 80(1):22-33. PubMed ID: 9210705
[TBL] [Abstract][Full Text] [Related]
49. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
50. Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters.
Cengiz C; Akarca US; Goker E; Yuce G
Dig Dis Sci; 2003 May; 48(5):865-9. PubMed ID: 12772781
[TBL] [Abstract][Full Text] [Related]
51. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines.
Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y
Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407
[TBL] [Abstract][Full Text] [Related]
52. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
53. Pathogenesis and treatment of hepatitis C virus-related liver diseases.
Tanikawa K
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):17-20. PubMed ID: 14969831
[TBL] [Abstract][Full Text] [Related]
54. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
55. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.
Tornillo L; Carafa V; Richter J; Sauter G; Moch H; Minola E; Gambacorta M; Bianchi L; Vecchione R; Terracciano LM
J Pathol; 2000 Nov; 192(3):307-12. PubMed ID: 11054713
[TBL] [Abstract][Full Text] [Related]
56. Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene.
Tanabe A; Konno J; Tanikawa K; Sahara H
Gene; 2014 Feb; 535(1):24-32. PubMed ID: 24269672
[TBL] [Abstract][Full Text] [Related]
57. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?
Kałużna EM
Rev Med Virol; 2014 May; 24(3):169-85. PubMed ID: 24591085
[TBL] [Abstract][Full Text] [Related]
60. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
